Renhe Pharmacy Co.,Ltd Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Cash & Equivalents	1,095	2,329	2,615	2,825	2,360	1,726
Short-Term Investments	52.52	385.49	155.37	290.03	100	700
Trading Asset Securities	2,915	1,017	764.59	416.87	315.6	460.89
Cash & Short-Term Investments	4,063	3,731	3,534	3,532	2,776	2,887
Cash Growth	21.13%	5.57%	0.06%	27.25%	-3.83%	29.77%
Accounts Receivable	650.63	466.59	500.18	477.59	539.8	467.01
Other Receivables	11.86	6.03	8.26	8.82	10.02	6
Receivables	662.49	472.62	508.44	486.41	549.82	473.01
Inventory	399.72	486.94	446.58	457.74	601.35	465.35
Other Current Assets	97.41	129.04	94.2	104.33	128.46	63.18
Total Current Assets	5,222	4,820	4,584	4,581	4,056	3,888
Property, Plant & Equipment	1,398	1,423	1,250	1,241	1,112	751.35
Long-Term Investments	31.46	32.4	30.48	536.41	392.69	900
Goodwill	501.91	501.91	546.91	578.24	606.12	102.2
Other Intangible Assets	303.88	313.44	420.72	582.87	342.74	356.78
Long-Term Deferred Tax Assets	29.25	32.65	28.25	20.85	6.64	5.9
Long-Term Deferred Charges	13.69	14.59	16.34	22.93	310.64	311.47
Other Long-Term Assets	603.78	345.14	568.04	71.9	81.83	53.12
Total Assets	8,104	7,482	7,445	7,635	6,908	6,369
Accounts Payable	524.26	132.08	123.5	199.62	176.08	162.93
Accrued Expenses	32.29	28.46	33.49	103.52	110.71	71.89
Short-Term Debt	-	-	-	-	-	60.05
Current Portion of Leases	0.55	0.69	5.79	6.72	2.84	1.66
Current Income Taxes Payable	121.84	72.54	209.63	224.76	211.59	101.42
Current Unearned Revenue	63.42	107.67	124.94	354.56	200.61	84.46
Other Current Liabilities	282.45	294.91	253.67	275.33	266.84	234.64
Total Current Liabilities	1,025	636.35	751.01	1,165	968.66	717.04
Long-Term Leases	1.47	1.89	-	5.79	3.62	2.72
Long-Term Unearned Revenue	33.63	37.96	37.11	38.83	8.25	9.39
Long-Term Deferred Tax Liabilities	0.19	0.11	1.88	3.66	0.28	0.25
Other Long-Term Liabilities	0.18	0.18	0.18	0.18	0.18	0.18
Total Liabilities	1,060	676.48	790.18	1,213	981	729.59
Common Stock	1,400	1,400	1,400	1,400	1,400	1,400
Additional Paid-In Capital	803.07	796.39	810.81	785.76	766.66	957.06
Retained Earnings	4,213	4,044	3,842	3,555	3,121	2,736
Treasury Stock	-64.64	-66.96	-60.08	-	-	-
Total Common Equity	6,352	6,174	5,993	5,741	5,287	5,093
Minority Interest	691.72	632.32	661.46	681	639.65	546.67
Shareholders' Equity	7,044	6,806	6,655	6,422	5,927	5,639
Total Liabilities & Equity	8,104	7,482	7,445	7,635	6,908	6,369
Total Debt	2.02	2.58	5.79	12.52	6.46	64.44
Net Cash (Debt)	4,061	3,729	3,529	3,520	2,770	2,822
Net Cash Growth	21.09%	5.67%	0.25%	27.09%	-1.86%	26.87%
Net Cash Per Share	2.91	2.67	2.52	2.51	2.00	2.24
Filing Date Shares Outstanding	1,401	1,307	1,384	1,400	1,400	1,400
Total Common Shares Outstanding	1,401	1,307	1,391	1,400	1,400	1,400
Working Capital	4,197	4,183	3,833	3,416	3,087	3,171
Book Value Per Share	4.53	4.72	4.31	4.10	3.78	3.64
Tangible Book Value	5,546	5,358	5,025	4,580	4,338	4,634
Tangible Book Value Per Share	3.96	4.10	3.61	3.27	3.10	3.31
Buildings	-	1,516	1,163	1,001	665.33	637.87
Machinery	-	548.17	539.32	549.98	513.22	463.07
Construction In Progress	-	230.72	345.43	409.27	580.58	233.18

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.